BE629779A - - Google Patents
Info
- Publication number
- BE629779A BE629779A BE629779DA BE629779A BE 629779 A BE629779 A BE 629779A BE 629779D A BE629779D A BE 629779DA BE 629779 A BE629779 A BE 629779A
- Authority
- BE
- Belgium
- Prior art keywords
- hydantolne
- parts
- nyl
- hydantoin
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 20
- IQPQWNKOIGAROB-UHFFFAOYSA-N [N-]=C=O Chemical compound [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- -1 methoxy, phenyl Chemical group 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 15
- WJRBRSLFGCUECM-UHFFFAOYSA-N Hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims description 13
- 229940091173 hydantoin Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 150000007945 N-acyl ureas Chemical class 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 239000003085 diluting agent Substances 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- CXOFVDLJLONNDW-UHFFFAOYSA-N Epinat Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 125000004429 atoms Chemical group 0.000 claims description 4
- 125000004430 oxygen atoms Chemical group O* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000005219 aminonitrile group Chemical group 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 240000003670 Sesamum indicum Species 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 239000004519 grease Substances 0.000 claims 1
- 125000001209 o-nitrophenyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])[N+]([O-])=O 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 238000002844 melting Methods 0.000 description 19
- 239000007787 solid Substances 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000010992 reflux Methods 0.000 description 11
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- YGYAWVDWMABLBF-UHFFFAOYSA-N phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- JQULXIOYDDCNGR-UHFFFAOYSA-N 2-amino-2-methylpropanenitrile Chemical compound CC(C)(N)C#N JQULXIOYDDCNGR-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 3
- UBPDKIDWEADHPP-UHFFFAOYSA-N 2-iodoaniline Chemical compound NC1=CC=CC=C1I UBPDKIDWEADHPP-UHFFFAOYSA-N 0.000 description 3
- 150000001469 hydantoins Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- VVNMGFXOVZRKQF-UHFFFAOYSA-N 1-iodo-2-isocyanatobenzene Chemical compound IC1=CC=CC=C1N=C=O VVNMGFXOVZRKQF-UHFFFAOYSA-N 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- 229940053195 antiepileptics Hydantoin derivatives Drugs 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- GOOVAYJIVMBWPP-UHFFFAOYSA-N 1-bromo-2-isocyanatobenzene Chemical compound BrC1=CC=CC=C1N=C=O GOOVAYJIVMBWPP-UHFFFAOYSA-N 0.000 description 1
- NOHQUGRVHSJYMR-UHFFFAOYSA-N 1-chloro-2-isocyanatobenzene Chemical compound ClC1=CC=CC=C1N=C=O NOHQUGRVHSJYMR-UHFFFAOYSA-N 0.000 description 1
- HHIRBXHEYVDUAM-UHFFFAOYSA-N 1-chloro-3-isocyanatobenzene Chemical compound ClC1=CC=CC(N=C=O)=C1 HHIRBXHEYVDUAM-UHFFFAOYSA-N 0.000 description 1
- SUVCZZADQDCIEQ-UHFFFAOYSA-N 1-isocyanato-2-methoxybenzene Chemical compound COC1=CC=CC=C1N=C=O SUVCZZADQDCIEQ-UHFFFAOYSA-N 0.000 description 1
- AOPBDRUWRLBSDB-UHFFFAOYSA-N 2-bromoaniline Chemical compound NC1=CC=CC=C1Br AOPBDRUWRLBSDB-UHFFFAOYSA-N 0.000 description 1
- VAYMIYBJLRRIFR-UHFFFAOYSA-N 2-tolyl isocyanate Chemical compound CC1=CC=CC=C1N=C=O VAYMIYBJLRRIFR-UHFFFAOYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- SBDPJLJFODHSFF-UHFFFAOYSA-N 4-chloro-1-isocyanato-2-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(Cl)=CC=C1N=C=O SBDPJLJFODHSFF-UHFFFAOYSA-N 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N Methyl radical Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 101710030983 RNF138 Proteins 0.000 description 1
- 101710029702 TICAM1 Proteins 0.000 description 1
- 101710021425 TRIM69 Proteins 0.000 description 1
- 102100003447 TRIM69 Human genes 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000001773 anti-convulsant Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 239000003179 convulsant agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 101700082297 nhr-2 Proteins 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE629779A true BE629779A (pt) |
Family
ID=199104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE629779D BE629779A (pt) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE629779A (pt) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3463787A (en) * | 1968-05-31 | 1969-08-26 | Sterling Drug Inc | 4-imino-3-phenyl-2-oxoimidazolidine-1-acetonitriles |
| US3668217A (en) * | 1968-11-25 | 1972-06-06 | Sumitomo Chemical Co | 3-(3{40 ,5{40 -dihalogenophenyl)imidazolidine-2,4-dione derivatives |
| US3846441A (en) * | 1970-12-09 | 1974-11-05 | Sumitomo Chemical Co | 1,5-disubstituted-3-substituted phenyl hydantoins |
| EP0001813A1 (de) * | 1977-10-28 | 1979-05-16 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Imidazolidinderivate, Verfahren zu deren Herstellung, Zwischenprodukte zur Verwendung in diesem Verfahren, entsprechende pharmazeutische Präparate sowie die Verwendung der Wirkstoffe |
| US4234736A (en) * | 1977-10-28 | 1980-11-18 | Hoffmann-La Roche Inc. | Antiandrogenic and schistosomicidal imidazolidine derivatives |
-
0
- BE BE629779D patent/BE629779A/fr unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3463787A (en) * | 1968-05-31 | 1969-08-26 | Sterling Drug Inc | 4-imino-3-phenyl-2-oxoimidazolidine-1-acetonitriles |
| US3668217A (en) * | 1968-11-25 | 1972-06-06 | Sumitomo Chemical Co | 3-(3{40 ,5{40 -dihalogenophenyl)imidazolidine-2,4-dione derivatives |
| US3846441A (en) * | 1970-12-09 | 1974-11-05 | Sumitomo Chemical Co | 1,5-disubstituted-3-substituted phenyl hydantoins |
| EP0001813A1 (de) * | 1977-10-28 | 1979-05-16 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Imidazolidinderivate, Verfahren zu deren Herstellung, Zwischenprodukte zur Verwendung in diesem Verfahren, entsprechende pharmazeutische Präparate sowie die Verwendung der Wirkstoffe |
| FR2422643A1 (fr) * | 1977-10-28 | 1979-11-09 | Hoffmann La Roche | Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments |
| US4234736A (en) * | 1977-10-28 | 1980-11-18 | Hoffmann-La Roche Inc. | Antiandrogenic and schistosomicidal imidazolidine derivatives |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2107484C (fr) | Nouveaux arylalkyl(thio)amides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CA2045445A1 (fr) | Nouveaux composes de l'acide 4-amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent | |
| CA1111027A (fr) | Aza-8 purinones-6 | |
| BE629779A (pt) | ||
| EP0573318A1 (fr) | Nouveaux dérivés de phényle carboxamide isoxazoles et leurs sels, leur procédé de préparation et les nouveaux intermédiaires de ce procédé, leur application comme médicaments et les compositions pharmaceutiques les renfermant | |
| FR2615188A1 (fr) | Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant | |
| FR2552083A1 (fr) | Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique | |
| CH615417A5 (pt) | ||
| FR2822463A1 (fr) | Derives bicycliques de guanidines et leurs applications en therapeutique | |
| CH594650A5 (en) | Antiinflammatory (1,2)-benzothiazine derivs. prepn. | |
| BE884977A (fr) | Nouveau n-phenyl-benzamides utiles dans le traitement de l'inflammation et de la douleur des mammiferes | |
| FR2695640A1 (fr) | Dérivés d'(amino-3 phényl)-1 éthanesulfonate d'alkylammonium optiquement actifs, leur préparation et leur utilisation. | |
| EP0233801A1 (fr) | Nouveaux amides substitués, leur préparation et les compositions pharmaceutiques qui les contiennent | |
| WO2012104538A1 (fr) | Nouveaux dérivés de 1, 5 - dihydropyrrol - 2 - one utiles pour le traitement paludisme ou d'autres maladies parasitaires et fongiques | |
| FR2588003A1 (fr) | Derives de 1,4-dihydropyridine-sulfone, procedes de preparation de ces composes et compositions pharmaceutiques les comprenant | |
| BE561270A (pt) | ||
| LU81891A1 (fr) | Derives d'amino-3 dioxo-2,4(1h,3h)quinazolines,leur procede de preparation et composition therapeutique les contenant | |
| FR2508038A1 (fr) | Derives d'acide aminosulfonylbenzoique utiles comme medicaments | |
| FR2725201A1 (fr) | Procede de preparation de derives du nitrobenzene | |
| BE844832A (fr) | Nouvelles amidinourees, leur preparation et leur emploi | |
| BE577496A (pt) | ||
| BE519639A (pt) | ||
| BE551306A (pt) | ||
| BE559968A (pt) | ||
| BE668497A (pt) |